Literature DB >> 23992892

Epidemiology of foot ulceration and amputation: can global variation be explained?

David J Margolis1, William Jeffcoate.   

Abstract

Amputation is a treatment, and not simply part of the natural history of foot disease. However, assessment of amputation incidence is the measure most frequently used to document an outcome reflecting the management of diabetic foot disease, mainly because the data are already captured in most health care systems. Nevertheless, interpretation of the results requires great care. Many centers have recorded decreases in the incidence of amputation in recent years and have concluded that this reflects improvement in clinical care. Although improvement in clinical care is clearly of a priority, it is important not to underestimate the extent to which the at-risk population (those with diabetes) may have changed as a result of changing criteria for the diagnosis of diabetes, as well as the increasing implementation of systematic and opportunistic screening. The incidence of amputation can be calculated and expressed in many ways, with different groups using different criteria for deciding both the numerator and the denominator, and studying populations that may differ in several different ways. Given that the incidence of amputation can also be influenced by a wide variety of clinical and social factors, it is not surprising that considerable variation exists between published studies from different countries. For these reasons it is currently difficult to make meaningful comparisons between data from different countries. On the other hand, the demonstration of wide variation within a single country or between countries or communities that have very similar populations, health care systems, and procedures for documenting amputation incidence is of greater interest. When 8- to 10-fold variation exists within similar health care systems, a risk as large as any published risk factor for amputation, it is essential that the reasons are explored. While race and social deprivation both make an important contribution to variation, another is likely to relate to aspects of the structure of care, including the training and beliefs of individual clinicians, patients’ access to care, preferences of patients, and the ability of a patient to understand the need for care and execute a care plan. This area of study requires further investigation.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; Epidemiology; Global variation; Incidence; Lower extremity amputation

Mesh:

Year:  2013        PMID: 23992892     DOI: 10.1016/j.mcna.2013.03.008

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  22 in total

1.  NOS1AP genetic variation is associated with impaired healing of diabetic foot ulcers and diminished response to healing of circulating stem/progenitor cells.

Authors:  David J Margolis; Michelle Hampton; Ole Hoffstad; D Scot Mala; Ziad Mirza; Diana Woltereck; Steven Shannon; Michael A Troiano; Nandita Mitra; Ming Yang; Veena M Bhopale; Stephen R Thom
Journal:  Wound Repair Regen       Date:  2017-08-14       Impact factor: 3.617

2.  Variants in genes belonging to the fibroblast growth factor family are associated with lower extremity amputation in non-Hispanic whites: Findings from the chronic renal insufficiency cohort study.

Authors:  Jayanta Gupta; Nandita Mitra; Raymond R Townsend; Michael Fischer; Jeffrey R Schelling; David J Margolis
Journal:  Wound Repair Regen       Date:  2016-06-20       Impact factor: 3.617

3.  Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults : A Prospective Cohort Study.

Authors:  Caitlin W Hicks; Dan Wang; Kunihiro Matsushita; B Gwen Windham; Elizabeth Selvin
Journal:  Ann Intern Med       Date:  2020-12-08       Impact factor: 25.391

4.  Health literacy and diabetic foot ulcer healing.

Authors:  David J Margolis; Michelle Hampton; Ole Hoffstad; D Scot Malay; Stephen Thom
Journal:  Wound Repair Regen       Date:  2015-06-19       Impact factor: 3.617

Review 5.  Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes.

Authors:  Caitlin W Hicks; Elizabeth Selvin
Journal:  Curr Diab Rep       Date:  2019-08-27       Impact factor: 4.810

Review 6.  Chronic wounds.

Authors:  Vincent Falanga; Roslyn Rivkah Isseroff; Athena M Soulika; Marco Romanelli; David Margolis; Suzanne Kapp; Mark Granick; Keith Harding
Journal:  Nat Rev Dis Primers       Date:  2022-07-21       Impact factor: 65.038

Review 7.  Preventing and treating foot complications associated with diabetes mellitus.

Authors:  Frank L Bowling; S Tawqeer Rashid; Andrew J M Boulton
Journal:  Nat Rev Endocrinol       Date:  2015-08-18       Impact factor: 43.330

8.  Assessing data on the incidence of lower limb amputation in diabetes.

Authors:  William Jeffcoate; Frances Game; Stephan Morbach; Maria Narres; Kristien Van Acker; Andrea Icks
Journal:  Diabetologia       Date:  2021-03-30       Impact factor: 10.122

9.  Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: the BRAZUPA study.

Authors:  Maria Candida R Parisi; Arnaldo Moura Neto; Fabio H Menezes; Marilia Brito Gomes; Rodrigo Martins Teixeira; José Egídio Paulo de Oliveira; Joana Rodrigues Dantas Pereira; Reine Marie Chaves Fonseca; Lorena Barreto Arruda Guedes; Adriana Costa E Forti; Ana Mayra Andrade de Oliveira; Marta Barreto de Medeiros Nóbrega; Víctor Nóbrega Quintas Colares; Helena Schmid; Otto Henrique Nienov; Marcia Nery; Túlio Diniz Fernandes; Hermelinda C Pedrosa; Cristina da S Schreiber de Oliveira; Marcelo Ronsoni; Karla Freire Rezende; Maria Teresa Verrone Quilici; Alexandre Eduardo Franzin Vieira; Geisa Maria Campos de Macedo; Eliana Gabas Stuchi-Perez; Kandir Genésio Innocenti Dinhane; Ana Emilia Pace; Maria Cristina Foss de Freitas; Maria Regina Calsolari; Mario José Abdalla Saad
Journal:  Diabetol Metab Syndr       Date:  2016-03-17       Impact factor: 3.320

10.  Lower extremity amputation rates in people with diabetes as an indicator of health systems performance. A critical appraisal of the data collection 2000-2011 by the Organization for Economic Cooperation and Development (OECD).

Authors:  F Carinci; M Massi Benedetti; N S Klazinga; L Uccioli
Journal:  Acta Diabetol       Date:  2016-07-21       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.